Cargando…

Proton Pump Inhibitors and Clostridium Difficile Infection: Are We Propagating an Already Rapidly Growing Healthcare Problem?

Proton pump inhibitors (PPIs) have been associated with Clostridium difficile infection (CDI) in several recent studies. The exact mechanism through which PPIs may cause Clostridium difficile infection is not well understood. One potential mechanism to explain this association may be that elevated g...

Descripción completa

Detalles Bibliográficos
Autores principales:	Patil, Rashmee, Blankenship, LeAnn
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elmer Press 2013
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5051091/ https://www.ncbi.nlm.nih.gov/pubmed/27785249 http://dx.doi.org/10.4021/gr575w

Ejemplares similares

Proton pump inhibitors and the incidence of Clostridium difficile on the intensive care unit
por: Whitehead, I, et al.
Publicado: (2007)

The Positive Association between Proton Pump Inhibitors and Clostridium Difficile Infection
por: Tawam, Dania, et al.
Publicado: (2021)

Proton-Pump Inhibitor Use and the Risk of Community-Associated Clostridium difficile Infection
por: Inghammar, Malin, et al.
Publicado: (2021)

Proton pump inhibitors and 180-day mortality in the elderly after Clostridium difficile treatment
por: Bradley, Evan Stuart, et al.
Publicado: (2019)

515. Estimating the Effect of Proton Pump Inhibitor Stewardship in Reducing Clostridium difficile Transmission
por: Lofgren, Eric, et al.
Publicado: (2018)

Clostridium difficile Infection and Proton Pump Inhibitor Use in Hospitalized Pediatric Cystic Fibrosis Patients
por: Pohl, John F., et al.
Publicado: (2011)

Proton pump inhibitors therapy and risk of Clostridium difficile infection: Systematic review and meta-analysis
por: Trifan, Anca, et al.
Publicado: (2017)

Recurrence and death after Clostridium difficile infection: gender-dependant influence of proton pump inhibitor therapy
por: Dos Santos-Schaller, Ophélie, et al.
Publicado: (2016)

Prolonged use of a proton pump inhibitor reduces microbial diversity: implications for Clostridium difficile susceptibility
por: Seto, Charlie T, et al.
Publicado: (2014)

Proton pump inhibitors increase the risk for hospital-acquired Clostridium difficile infection in critically ill patients
por: Barletta, Jeffrey F, et al.
Publicado: (2014)

Burden of Clostridium difficile on the Healthcare System
por: Dubberke, Erik R., et al.
Publicado: (2012)

Erratum to: Prolonged use of a proton pump inhibitor reduces microbial diversity: implications for Clostridium difficile susceptibility
por: Seto, Charlie T., et al.
Publicado: (2016)

Proton Pump Inhibitors Should be Used with Caution in Critically Ill Patients to Prevent the Risk of Clostridium difficile Infection
por: Min, Jung Hwa, et al.
Publicado: (2016)

Association between Proton Pump Inhibitor Therapy and Clostridium difficile Infection: A Contemporary Systematic Review and Meta-Analysis
por: Tleyjeh, Imad M., et al.
Publicado: (2012)

Risk of Clostridium difficile Infection with the Use of a Proton Pump Inhibitor for Stress Ulcer Prophylaxis in Critically Ill Patients
por: Ro, Youngouk, et al.
Publicado: (2016)

Outpatient Healthcare Settings and Transmission of Clostridium difficile
por: Jury, Lucy A., et al.
Publicado: (2013)

Clostridium difficile colitis – a serious current problem
por: Dumitru, Irina Magdalena, et al.
Publicado: (2013)

Effects of proton pump inhibitors and histamine-2 receptor antagonists on response to fidaxomicin or vancomycin in patients with Clostridium difficile-associated diarrhoea
por: Weiss, Karl, et al.
Publicado: (2015)

Prevalence of Clostridium difficile colonization among healthcare workers
por: Friedman, N Deborah, et al.
Publicado: (2013)

NAFLD‐related hepatocellular carcinoma: The growing challenge
por: Shah, Pir Ahmad, et al.
Publicado: (2023)

Prevention of Clostridium difficile Infection and Associated Diarrhea: An Unsolved Problem
por: Principi, Nicola, et al.
Publicado: (2020)

Evaluation of the Xpert Clostridium difficile Assay for the Diagnosis of Clostridium difficile Infection
por: Shin, Saeam, et al.
Publicado: (2012)

Emergence and global spread of epidemic healthcare-associated Clostridium difficile
por: He, Miao, et al.
Publicado: (2012)

Quantifying Transmission of Clostridium difficile within and outside Healthcare Settings
por: Durham, David P., et al.
Publicado: (2016)

1628 Accuracy of Healthcare Facility-Onset Clostridium difficile Classification
por: Trappler, Regan, et al.
Publicado: (2014)

Gut Microbiota and Clostridium difficile: What We Know and the New Frontiers
por: Piccioni, Andrea, et al.
Publicado: (2022)

Does Proton Pump Inhibitor Increase the Clostridium difficile Infection Risk in the Treatment and Prophylaxis of Stress Ulcers than Histanime-2 Receptor Antagonist?
por: Eun, Chang Soo
Publicado: (2017)

Let the proton smashing begin (The rap is already written)
por: Overbye , Dennis
Publicado: (2008)

COVID-19 and healthcare lessons already learned
por: Terry, Nicolas
Publicado: (2020)

Immunopathogenesis of Human Sporotrichosis: What We Already Know
por: Conceição-Silva, Fatima, et al.
Publicado: (2018)

Etymologia: Clostridium difficile
Publicado: (2010)

Clostridium: Transmission difficile?
por: Harbarth, Stephan, et al.
Publicado: (2012)

Clostridium difficile Infection
por: Feuerstadt, Paul
Publicado: (2015)

Clostridium difficile infection
por: Geller, Stephen A., et al.
Publicado: (2014)

Clostridium difficile Infection
por: Magdesian, K. Gary
Publicado: (2003)

P029: Regional differences in Clostridium difficile infections (CDI) in relation to fluoroquinolone (FQ) and proton pump inhibitor (PPI) use, Finland, 2008-2011
por: Kanerva, M, et al.
Publicado: (2013)

Already!
Publicado: (1892)

Community- and Healthcare-Associated Clostridium difficile Infections, Finland, 2008−2013
por: Kotila, Saara M., et al.
Publicado: (2016)

Etiology of Infectious Diarrhea in Patients Tested for Clostridium difficile: If It Isn’t Clostridium difficile, What Is It?
por: Kwon, Jennie H, et al.
Publicado: (2017)

Problems Associated with Deprescribing of Proton Pump Inhibitors
por: Helgadottir, Holmfridur, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_0p39p6fumrka5oj5g53iioofi7